Burgeoning Obesity Market Attracts Takeda and Amylin
By Taskin Ahmed
Pharma Deals Review: Vol 2009 Issue 11 (Table of Contents)
Published: 10 Nov-2009
DOI: 10.3833/pdr.v2009.i11.1270 ISSN: 1756-7874
Section: Licensing
Fulltext:
Abstract
Takeda and Amylin have signed a worldwide development and commercialization agreement to advance obesity drugs in a deal that could be worth up to US$1 B...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS